rs777218310
Variant summary
Our verdict is Pathogenic. Variant got 11 ACMG points: 11P and 0B. PVS1PM2PP5
The NM_004092.4(ECHS1):c.410_411delAT(p.Tyr137CysfsTer7) variant causes a frameshift change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000229 in 1,613,352 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_004092.4 frameshift
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 11 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000985 AC: 15AN: 152224Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000159 AC: 4AN: 251002Hom.: 0 AF XY: 0.0000221 AC XY: 3AN XY: 135766
GnomAD4 exome AF: 0.0000151 AC: 22AN: 1461128Hom.: 0 AF XY: 0.00000825 AC XY: 6AN XY: 726838
GnomAD4 genome AF: 0.0000985 AC: 15AN: 152224Hom.: 0 Cov.: 32 AF XY: 0.0000941 AC XY: 7AN XY: 74370
ClinVar
Submissions by phenotype
not provided Pathogenic:3Uncertain:1
This variant is expected to result in the loss of a functional protein. The frequency of this variant in the general population is consistent with pathogenicity (http://gnomad.broadinstitute.org). This variant has been identified in at least one individual tested at Athena Diagnostics with clinical features associated with this gene.This observation is not an independent occurrence and has been identified in the same individual by RCIGM, the other laboratory participating in the GEMINI study. -
Reported in another patient with mitochondrial short chain enoyl-CoA hydratase 1 deficiency who was also heterozygous for another variant in ECHS1 (Aljishi et al., 2019); Frameshift variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss-of-function is a known mechanism of disease; This variant is associated with the following publications: (PMID: 28755360, 28409271, 28106320, 27905109, 28202214, 28039521, 27221955, 27090768, 26920905, 26099313, 26081110, 26000322, 25393721, 25125611, Aljishi2019[casereport], 31216405) -
This sequence change creates a premature translational stop signal (p.Tyr137Cysfs*7) in the ECHS1 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in ECHS1 are known to be pathogenic (PMID: 25393721, 26000322, 27090768). This variant is present in population databases (rs777218310, gnomAD 0.02%). This variant has not been reported in the literature in individuals affected with ECHS1-related conditions. ClinVar contains an entry for this variant (Variation ID: 418830). For these reasons, this variant has been classified as Pathogenic. -
- -
Inborn genetic diseases Pathogenic:1
- -
Mitochondrial short-chain Enoyl-Coa hydratase 1 deficiency Pathogenic:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at